Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 834
Filtrer
1.
Food Chem ; 462: 141008, 2025 Jan 01.
Article de Anglais | MEDLINE | ID: mdl-39217746

RÉSUMÉ

Hydrophobic bioactive compounds like astaxanthin (AST) exhibit poor water solubility and low bioavailability. Liposomes, which serve as nanocarriers, are known for their excellent biocompatibility and minimal immunogenicity. Traditionally, liposomes have been primarily constructed using phospholipids and cholesterol. However, the intake of cholesterol may pose a risk to human health. Phytosterol ester was reported to reduce level of cholesterol and improve properties of liposomes. In this study, phytosterol oleate was used to prepare liposomes instead of cholesterol to deliver AST (AST-P-Lip). The size range of AST-P-Lip was 100-220 nm, and the morphology was complete and uniform. In vitro studies showed that AST-P-Lip significantly enhanced the antioxidant activity and oral bioavailability of AST. During simulated digestion, AST-P-Lip protected AST from damage by gastric and intestinal digestive fluid. Additionally, AST-P-Lip had a good storage stability and safety. These results provide references for the preparation of novel liposomes and the delivery of bioactive compounds.


Sujet(s)
Cholestérol , Liposomes , Phytostérols , Xanthophylles , Liposomes/composition chimique , Xanthophylles/composition chimique , Xanthophylles/pharmacologie , Xanthophylles/administration et posologie , Humains , Phytostérols/composition chimique , Phytostérols/pharmacologie , Phytostérols/administration et posologie , Cholestérol/composition chimique , Taille de particule , Biodisponibilité , Acide oléique/composition chimique , Préparation de médicament , Animaux , Antioxydants/composition chimique , Antioxydants/pharmacologie
2.
Diabetes Ther ; 15(11): 2351-2366, 2024 Nov.
Article de Anglais | MEDLINE | ID: mdl-39283411

RÉSUMÉ

INTRODUCTION: We aim to evaluate the efficacy and safety of pioglitazone/metformin fixed-dose combination (FDC) versus uptitrated metformin in patients with type 2 diabetes mellitus (T2DM) without adequate glycemic control. METHODS: A total of 304 patients were recruited from 15 hospitals in China and randomly assigned (1:1) to the test group (pioglitazone/metformin FDC, 15/500 mg) or the control group (uptitrated metformin, 2000-2500 mg/day). The primary endpoint was the proportion of patients with glycated hemoglobin A1c (HbA1c) ≤ 6.5% and ≤ 7.0% at week 16. The secondary outcomes included the change from baseline in glucose, serum lipids, and liver function. Full analysis set (FAS) and per-protocol set (PPS) were used for analyses. RESULTS: In the test group, 103 (69.59%) patients reached HbA1c ≤ 7.0% (FAS, P = 0.009), with 68 (45.95%) patients achieved HbA1c ≤ 6.5 (FAS, P = 0.043). More reduction in HbA1c, homeostatic model assessment for insulin resistance, and diastolic pressure was found. Bodyweight, body mass index, and high-density lipoprotein cholesterol increased markedly. The changes of triglycerides, alanine transaminase, aspartate aminotransferase, and high-sensitivity C-reactive protein decreased noticeably. There were no significant differences in rates of adverse events between the two groups. CONCLUSIONS: Pioglitazone/metformin FDC was superior to uptitrated metformin among patients with T2DM without adequate glycemic control. TRIAL REGISTRATION NUMBER: This trial is registered with the Chinese Clinical Trial Registry (ChiCTR1900028606).

3.
J Pharmacol Sci ; 156(2): 49-56, 2024 Oct.
Article de Anglais | MEDLINE | ID: mdl-39179334

RÉSUMÉ

The need for novel anti-thyroid cancer (TC) medications is urgent due to the rising incidence and metastatic rates of malignant TC. In this study, we investigated the effect of Polyphyllin VII (PPVII) to TC cells, and explored their potential mechanism. B-CPAP and TPC-1 cells, were used to analyze the antitumor activity of PPVII by quantifying cell growth and metastasis as well as to study the effect on epithelial mesenchymal transition (EMT). The results showed that PPVII dramatically reduced the capacity of B-CPAP and TPC-1 cells to proliferate and migrate in a dose-response manner. Following PPVII treatment of TC cells, the expression levels of E-cadherin progressively increased and were higher than the control group, while the expression levels of EMT-related genes Vimentin, N-cadherin, Slug, Zeb-1, and Foxe1 gradually declined and were lower than the control group. It was proposed that PPVII might prevent TC from undergoing EMT. The Foxe1 gene was shown to be significantly expressed in TC, and a statistically significant variation in Foxe1 expression was observed across clinical stages of the disease, according to a bioinformatics database study. There was a strong link between the expression of the Foxe1 gene and the EMT-related gene. In the meantime, TC cells' expression of Foxe1 can be inhibited by PPVII. In conclusion, our results showed that PPVII may as a potential medication for targeting EMT in thyroid cancer.


Sujet(s)
Cadhérines , Mouvement cellulaire , Prolifération cellulaire , Transition épithélio-mésenchymateuse , Saponines , Tumeurs de la thyroïde , Transition épithélio-mésenchymateuse/effets des médicaments et des substances chimiques , Transition épithélio-mésenchymateuse/génétique , Humains , Tumeurs de la thyroïde/traitement médicamenteux , Tumeurs de la thyroïde/anatomopathologie , Tumeurs de la thyroïde/génétique , Prolifération cellulaire/effets des médicaments et des substances chimiques , Cadhérines/métabolisme , Cadhérines/génétique , Saponines/pharmacologie , Saponines/usage thérapeutique , Lignée cellulaire tumorale , Mouvement cellulaire/effets des médicaments et des substances chimiques , Facteurs de transcription Forkhead/génétique , Facteurs de transcription Forkhead/métabolisme , Relation dose-effet des médicaments , Expression des gènes/effets des médicaments et des substances chimiques , Thérapie moléculaire ciblée , Antinéoplasiques/pharmacologie
4.
Discov Oncol ; 15(1): 367, 2024 Aug 25.
Article de Anglais | MEDLINE | ID: mdl-39182013

RÉSUMÉ

Colorectal cancer is a common malignant tumor of the digestive system. Its morbidity and mortality rank among the highest in the world. Cancer development is associated with aberrant signaling pathways. Autophagy is a process of cell self-digestion that maintains the intracellular environment and has a bidirectional regulatory role in cancer. Apoptosis is one of the important death programs in cancer cells and is able to inhibit cancer development. Studies have shown that a variety of substances can regulate autophagy and apoptosis in colorectal cancer cells through signaling pathways, and participate in the regulation of autophagy on apoptosis. In this paper, we focus on the relevant research on autophagy in colorectal cancer cells based on the involvement of related signaling pathways in the regulation of apoptosis in order to provide new research ideas and therapeutic directions for the treatment of colorectal cancer.

5.
Cancer Control ; 31: 10732748241274196, 2024.
Article de Anglais | MEDLINE | ID: mdl-39215442

RÉSUMÉ

Background: Colorectal cancer is a major cause of mortality among the prevalent malignant tumors of the gastrointestinal tract. Although chemotherapy is a standard treatment for colorectal cancer, its efficacy is limited by chemoresistance. Recent studies have investigated targeting tumor stem cells as a potential new therapeutic approach for addressing chemoresistance in colorectal cancer. Colorectal cancer frequently relapses, with tumor stem cells often representing one of the leading causes of treatment failure. Purpose: Understanding drug resistance in colorectal cancer stem cells is crucial for improving treatment outcomes. By focusing on developing targeted therapies that specifically address drug resistance in colorectal cancer stem cells, there is potential to make significant advancements in the treatment of colorectal cancer.This approach may lead to more effective and lasting outcomes in patients battling colorectal cancer. Research Design: In this review, a comprehensive overview of recent research on colorectal cancer stem cell treatment resistance is presented.Results: Elucidating the key underlying mechanisms. This review also highlights the potential benefits of targeted therapies in overcoming colorectal cancer resistance to treatment. Conclusions: CCSCs are key players in drug resistance of CRC, indicating their potential as targets for effective therapy. Elucidating their role in this process could aid in discovering tailored treatment strategies.The significance of signaling pathways, TME, and miRNA in regulating drug resistance in CCSCs is been highlighted.


Sujet(s)
Tumeurs colorectales , Résistance aux médicaments antinéoplasiques , Cellules souches tumorales , Humains , Cellules souches tumorales/effets des médicaments et des substances chimiques , Cellules souches tumorales/anatomopathologie , Cellules souches tumorales/métabolisme , Tumeurs colorectales/traitement médicamenteux , Tumeurs colorectales/anatomopathologie , microARN/génétique , Transduction du signal/effets des médicaments et des substances chimiques , Antinéoplasiques/usage thérapeutique , Antinéoplasiques/pharmacologie
6.
J Hepatocell Carcinoma ; 11: 1569-1580, 2024.
Article de Anglais | MEDLINE | ID: mdl-39156675

RÉSUMÉ

Purpose: Oxidative stress plays a critical role in promoting tumor resistance to hypoxia and chemotherapeutic drugs. However, the prognostic role of oxidative stress-related genes (OSRGs) in hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE) has not been fully explored. Methods: We used transcriptome data from the GSE104580 cohort containing patients marked as responders or nonresponders to TACE therapy to identify differentially expressed OSRGs associated with TACE response (TR-OSRGs). We created a TR-OSRG prognostic signature based on TR-OSRGs using least absolute shrinkage and selection operator Cox and stepwise Cox regression analyses in a training cohort of patients with HCC (TCGA-LIHC). We verified this prognostic signature in two external cohorts of patients who received TACE for HCC (GSE14520-TACE and ZS-TACE-37). Finally, we constructed a prognostic nomogram model for predicting survival probability of patients with HCC based on Cox regression analysis. Results: The TR-OSRG prognostic signature was created and shown to be a robust independent prognostic factor for treatment response and outcomes for HCC after TACE therapy. Risk scores based on this signature correlated with tumor stage and grade. Tumor samples from patients with higher risk scores exhibited more infiltration of immune cells and significantly increased expression of immune checkpoint genes. We also developed a nomogram for patients with HCC based on the TR-OSRG prognostic signature and clinical parameters; this nomogram was a useful quantitative analysis tool for predicting patient survival. Conclusion: The TR-OSRGs signature exhibited good performance in predicting treatment response and outcomes in patients with HCC treated with TACE.

7.
Gigascience ; 132024 01 02.
Article de Anglais | MEDLINE | ID: mdl-39028585

RÉSUMÉ

Sex role differentiation is a widespread phenomenon. Sex pheromones are often associated with sex roles and convey sex-specific information. In Lepidoptera, females release sex pheromones to attract males, which evolve sophisticated olfactory structures to relay pheromone signals. However, in some primitive moths, sex role differentiation becomes diverged. Here, we introduce the chromosome-level genome assembly from ancestral Himalaya ghost moths, revealing a unique olfactory evolution pattern and sex role parity among Lepidoptera. These olfactory structures of the ghost moths are characterized by a dense population of trichoid sensilla, both larger male and female antennal entry parts of brains, compared to the evolutionary later Lepidoptera. Furthermore, a unique tandem of 34 odorant receptor 19 homologs in Thitarodes xiaojinensis (TxiaOr19) has been identified, which presents overlapped motifs with pheromone receptors (PRs). Interestingly, the expanded TxiaOr19 was predicted to have unconventional tuning patterns compared to canonical PRs, with nonsexual dimorphic olfactory neuropils discovered, which contributes to the observed equal sex roles in Thitarodes adults. Additionally, transposable element activity bursts have provided traceable loci landscapes where parallel diversifications occurred between TxiaOr19 and PRs, indicating that the Or19 homolog expansions were diversified to PRs during evolution and thus established the classic sex roles in higher moths. This study elucidates an olfactory prototype of intermediate sex communication from Himalaya ghost moths.


Sujet(s)
Papillons de nuit , Animaux , Papillons de nuit/génétique , Papillons de nuit/physiologie , Mâle , Femelle , Phéromones sexuelles/métabolisme , Récepteurs olfactifs/génétique , Récepteurs olfactifs/métabolisme , Récepteurs aux phéromones/génétique , Récepteurs aux phéromones/métabolisme , Phylogenèse , Comportement sexuel chez les animaux
8.
Ann Vasc Surg ; 108: 266-278, 2024 Nov.
Article de Anglais | MEDLINE | ID: mdl-38942376

RÉSUMÉ

OBJECTIVE: To examine the efficacy of antegrade and retrograde approaches with the AngioJet thrombectomy device for the treatment of acute lower limb deep vein thrombosis (DVT) and to evaluate the necessity of filter placement. METHODS: The clinical data of patients with acute lower limb DVT treated with the AngioJet device from January 2021 to June 2023 were retrospectively analyzed. The patients were divided into the antegrade and retrograde treatment groups according to the surgical approach and the direction of valve opening. The thrombosis interception rate of the filter, incidence of pulmonary embolism (PE), thrombectomy effectiveness, venous obstruction rate, and thrombosis recurrence rate of each treatment group were evaluated. In addition, factors affecting patency were analyzed. RESULTS: AngioJet was employed for 84 patients with acute lower limb DVT, treating a total of 88 limbs. The thrombosis interception rate of the filter was 35.7% (30 patients). The incidence of new PE or PE exacerbation was 6.0% (5 patients), and a filter retrieval rate of 97.6% (82 patients) was detected. Thrombus removal of grade III occurred in 35 (64.8%) of the 54 limbs (61.4%) in the antegrade treatment group versus 13 (38.2%) of the 34 limbs (38.6%) in the retrograde treatment group (P < 0.05). At 3 months, venous patency and bleeding events involved 52 (96.3%) and 4 (7.4%) limbs in the antegrade treatment group, respectively, versus 29 (85.3%) and 2 (5.9%) in the retrograde treatment group, respectively (P > 0.05). Regression analysis was performed to determine factors that may affect 3-month patency in both groups. Statistically significant linear relationships were found between 3-month patency and thrombus removal rate [odds ratio [OR] = 0.546 (0.326, 0.916)], thrombus formation time [OR = 1.018 (1.002, 1.036)], and preoperative thrombosis score [OR = 1.012 (1.002, 1.022)] in the antegrade treatment group, as well as thrombus removal rate [0.473 (0.229, 0.977)] in the retrograde treatment group. In regression analysis of factors affecting patency in both groups and the venous clinical severity score/Villalta score, a statistically significant linear relationship was found between thrombus formation time and the venous clinical severity score in the antegrade treatment group [0.576 (0.467, 0.710)]. CONCLUSIONS: Both antegrade and retrograde approaches are safe and effective for the treatment of acute lower limb DVT. There are no differences in 3-month deep vein patency and post-thrombotic syndrome (PTS) incidence rates. Individuals with acute lower limb DVT are at high risk of thrombus shedding after treatment with AngioJet thrombectomy, and placement of a vena cava filter (VCF) is recommended for effective interception.


Sujet(s)
Membre inférieur , Thrombectomie , Degré de perméabilité vasculaire , Thrombose veineuse , Humains , Études rétrospectives , Femelle , Mâle , Thrombose veineuse/thérapie , Thrombose veineuse/physiopathologie , Thrombose veineuse/imagerie diagnostique , Adulte d'âge moyen , Thrombectomie/instrumentation , Thrombectomie/effets indésirables , Résultat thérapeutique , Sujet âgé , Membre inférieur/vascularisation , Facteurs de risque , Facteurs temps , Adulte , Récidive , Maladie aigüe , Embolie pulmonaire/physiopathologie , Embolie pulmonaire/thérapie , Procédures endovasculaires/instrumentation , Procédures endovasculaires/effets indésirables
9.
Oral Dis ; 2024 Jun 24.
Article de Anglais | MEDLINE | ID: mdl-38923332

RÉSUMÉ

OBJECTIVES: Porphyromonas gingivalis-LPS regulated bone metabolism by triggering dysfunction of osteoblasts directly, and affecting activity of osteoclasts through intracellular communication. Exosome, as the mediator of intercellular communication, was important vesicle to regulate osteogenesis and osteoclastogenesis. This research was designed for investigating the mechanism of BMSCs-EXO in modulating osteoclastic activity under the P. gingivalis-LPS. MATERIALS AND METHODS: The cytotoxicity and osteogenic effects of P. gingivalis-LPS on BMSCs was evaluated, and then osteoclastic activity of RAW264.7 co-cultured with exosomes was detected. Besides, Affymetrix miRNA array and luciferase reporter assay were used to identify the target exosomal miRNA signal pathway. RESULTS: BMSCs' osteogenic differentiation and proliferation were decreased under 1 and 10 µg/mL P. gingivalis-LPS. Osteoclastic-related genes and proteins levels were promoted by P. gingivalis-LPS-stimulated BMSCs-EXO. Based on the miRNA microarray analysis, exosomal miR-151-3p was lessened in BMExo-LPS group, which facilitated osteoclastic differentiation through miR-151-3p/PAFAH1B1. CONCLUSIONS: Porphyromonas gingivalis-LPS could regulated bone metabolism by inhibiting proliferation and osteogenesis of BMSCs directly. Also, P. gingivalis-LPS-stimulated BMSCs-EXO promoted osteoclastogenesis via activating miR-151-3p/PAFAH1B1 signal pathway.

10.
Br J Nutr ; : 1-16, 2024 Jun 03.
Article de Anglais | MEDLINE | ID: mdl-38826079

RÉSUMÉ

This study was conducted to investigate whether methionyl-tRNA synthetase (MetRS) is a mediator of methionine (Met)-induced crop milk protein synthesis via the janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) signalling pathway in breeding pigeons. In Experiment 1, a total of 216 pairs of breeding pigeons were divided into three groups (control, Met-deficient, and Met-rescue groups). In Experiments 2 and 3, forty pairs of breeding pigeons from each experiment were allocated into four groups. The second experiment included a control group and three MetRS inhibitor (REP8839) groups. The third experiment included a Met-deficient group, Met-sufficient group, REP8839 + Met-deficient group and REP8839 + Met-sufficient group. Experiment 1 showed that Met supplementation increased crop development, crop milk protein synthesis, the protein expression of MetRS and JAK2/STAT5 signalling pathway, and improved squab growth. Experiment 2 showed that crop development, crop milk protein synthesis and the protein expression of MetRS and the JAK2/STAT5 signalling pathway were decreased, and squab growth was inhibited by the injection of 1·0 mg/kg body weight REP8839, which was the selected dose for the third experiment. Experiment 3 showed that Met supplementation increased crop development, crop milk protein synthesis and the expression of MetRS and JAK2/STAT5 signalling pathway and rescued squab growth after the injection of REP8839. Moreover, the co-immunoprecipitation results showed that there was an interaction between MetRS and JAK2. Taken together, these findings indicate that MetRS mediates Met-induced crop milk protein synthesis via the JAK2/STAT5 signalling pathway, resulting in improved squab growth in breeding pigeons.

11.
Accid Anal Prev ; 205: 107677, 2024 Sep.
Article de Anglais | MEDLINE | ID: mdl-38924963

RÉSUMÉ

Cycling, as a routine mode of travel, offers significant benefits in promoting health, eliminating emissions, and alleviating traffic congestion. Many cities, including London, have introduced various policies and measures to promote 'active travel' in view of its manifold advantages. Nevertheless, the reality is not as desirable as expected. Existing studies suggest that cyclists' perceptions of cycling safety significantly hinder the broader adoption of cycling. Our study investigates the perceived cycling safety and unpacks the association between the cycling safety level and the road environment, taking London as a case study. First, we proposed novel cycling safety level indicators that incorporate both collision and injury risks, based on which a tri-tiered cycling safety level prediction spanning the entirety of London's road network has been generated with good accuracy. Second, we assessed the road environment by harnessing imagery features of street view reflecting the cyclist's perception of space and combined it with road features of cycle accident sites. Finally, associations between road environment features and cycling safety levels have been explained using SHAP values, leading to tailored policy recommendations. Our research has identified several key factors that contribute to a risky environment for cycling. Among these, the "second road effects," which refers to roads intersecting with the road where the accident occurred, is the most critical to cycling safety levels. This would also support and further contribute to the literature on road safety. Other results related to road greenery, speed limits, etc, are also discussed in detail. In summary, our study offers insights into urban design and transport planning, emphasising the perceived cycling safety of road environment.


Sujet(s)
Accidents de la route , Cyclisme , Conception de l'environnement , Sécurité , Humains , Cyclisme/traumatismes , Cyclisme/psychologie , Accidents de la route/prévention et contrôle , Londres , Mâle , Adulte , Femelle , Perception , Adulte d'âge moyen , Jeune adulte
12.
Cancer Immunol Immunother ; 73(7): 119, 2024 May 07.
Article de Anglais | MEDLINE | ID: mdl-38713205

RÉSUMÉ

BACKGROUND: The programmed death 1 inhibitor toripalimab plus the angio-immuno kinase inhibitor surufatinib showed a tolerable safety profile and preliminary efficacy in patients with advanced solid tumors in a phase I study. METHODS: This open-label, multi-cohort study in China enrolled patients with advanced solid tumors who had failed or were intolerable to standard treatment into tumor-specific cohorts. Patients received surufatinib (250 mg orally, once daily) plus toripalimab (240 mg intravenously, once every three weeks). Results for three cohorts (gastric/gastroesophageal junction [GC/GEJ] adenocarcinoma, esophageal squamous cell carcinoma [ESCC], and biliary tract carcinoma [BTC]) are reported here. The primary endpoint was investigator-assessed objective response rate (ORR) per Response Evaluation criteria in Solid Tumors version 1.1. RESULTS: Between December 17, 2019, and January 29, 2021, 60 patients were enrolled (GC/GEJ, n = 20; ESCC, n = 20; BTC, n = 20). At data cutoff (February 28, 2023), ORRs were 31.6%, 30.0%, and 11.1%, respectively. Median progression-free survival was 4.1, 2.7, and 2.9 months, respectively. Median overall survival was 13.7, 10.4, and 7.0 months, respectively. Overall, grade ≥ 3 treatment-related adverse events occurred in 28 (46.7%) patients. CONCLUSIONS: Surufatinib plus toripalimab showed promising antitumor activity and a tolerable safety profile in immunotherapy-naïve patients with GC/GEJ adenocarcinoma, ESCC, or BTC. These findings warrant further study in larger randomized trials comparing surufatinib plus toripalimab with standard therapies in these tumors. CLINICALTRIALS: gov NCT04169672.


Sujet(s)
Adénocarcinome , Anticorps monoclonaux humanisés , Protocoles de polychimiothérapie antinéoplasique , Tumeurs des voies biliaires , Tumeurs de l'oesophage , Carcinome épidermoïde de l'oesophage , Humains , Mâle , Femelle , Adulte d'âge moyen , Sujet âgé , Anticorps monoclonaux humanisés/administration et posologie , Anticorps monoclonaux humanisés/effets indésirables , Anticorps monoclonaux humanisés/usage thérapeutique , Protocoles de polychimiothérapie antinéoplasique/usage thérapeutique , Protocoles de polychimiothérapie antinéoplasique/effets indésirables , Tumeurs de l'oesophage/traitement médicamenteux , Tumeurs de l'oesophage/anatomopathologie , Tumeurs des voies biliaires/traitement médicamenteux , Tumeurs des voies biliaires/anatomopathologie , Tumeurs des voies biliaires/mortalité , Adulte , Carcinome épidermoïde de l'oesophage/traitement médicamenteux , Carcinome épidermoïde de l'oesophage/anatomopathologie , Adénocarcinome/traitement médicamenteux , Adénocarcinome/anatomopathologie , Adénocarcinome/mortalité , Tumeurs de l'estomac/traitement médicamenteux , Tumeurs de l'estomac/mortalité , Tumeurs de l'estomac/anatomopathologie , Jonction oesogastrique/anatomopathologie , Imidazoles/administration et posologie , Imidazoles/usage thérapeutique , Imidazoles/effets indésirables , Sujet âgé de 80 ans ou plus , Études de cohortes
13.
Int J Pharm ; 659: 124291, 2024 Jun 25.
Article de Anglais | MEDLINE | ID: mdl-38821434

RÉSUMÉ

Hemophilic arthropathy (HA) is a condition caused by recurrent intra-articular bleeding in patients with hemophilia. Pro-inflammatory cytokines play a crucial role in the pathogenesis of HA. Our previous research demonstrated that a novel compound, piperazino-enaminone (JODI), effectively inhibited pro-inflammatory cytokines, including IL-6, MCP-1, MIP-1α, and MIP-1ß, in a mouse model of hemarthrosis. This study aims to enhance the anti-inflammatory effect of JODI by employing nanoparticle delivery systems, which could potentially improve its poor water solubility. Here, we developed liposomes modified with polyethylene glycol (PEG) for the delivery of JODI (JODI-LIP), and found that JODI-LIP exhibited uniform size, morphology, good stability and in vitro release degree. JODI-LIP mitigated cytotoxicity of JODI, and significantly suppressed the production of pro-inflammatory cytokines (TNF-α and IL-1ß) and nitric oxide (NO) release in RAW 264.7 cells stimulated by lipopolysaccharide (LPS), as well as the proliferation of human fibroblast-like synovial (HFLS) cells. In a murine model of HA, JODI-LIP demonstrated superior efficacy in ameliorating joint swelling and synovitis, compared to JODI. Importantly, JODI-LIP markedly reduced pro-inflammatory cytokines (TNF-α, IFN-γ, IL-33, and MCP-1) in injured joints. No hepatic or hematological toxicity was observed in mice treated with JODI-LIP. In summary, our results suggest that JODI-LIP holds promise as a therapeutic intervention for HA by attenuating pro-inflammatory cytokine levels.


Sujet(s)
Anti-inflammatoires , Cytokines , Modèles animaux de maladie humaine , Liposomes , Monoxyde d'azote , Animaux , Souris , Anti-inflammatoires/pharmacologie , Anti-inflammatoires/administration et posologie , Anti-inflammatoires/composition chimique , Cytokines/métabolisme , Cellules RAW 264.7 , Humains , Mâle , Monoxyde d'azote/métabolisme , Hémarthrose/traitement médicamenteux , Hémophilie A/traitement médicamenteux , Pipérazines/pharmacologie , Pipérazines/administration et posologie , Pipérazines/composition chimique , Polyéthylène glycols/composition chimique , Polyéthylène glycols/administration et posologie , Lipopolysaccharides
14.
Sci Rep ; 14(1): 9550, 2024 04 25.
Article de Anglais | MEDLINE | ID: mdl-38664461

RÉSUMÉ

DNA double-strand breaks (DSBs) activate DNA damage responses (DDRs) in both mitotic and meiotic cells. A single-stranded DNA (ssDNA) binding protein, Replication protein-A (RPA) binds to the ssDNA formed at DSBs to activate ATR/Mec1 kinase for the response. Meiotic DSBs induce homologous recombination monitored by a meiotic DDR called the recombination checkpoint that blocks the pachytene exit in meiotic prophase I. In this study, we further characterized the essential role of RPA in the maintenance of the recombination checkpoint during Saccharomyces cerevisiae meiosis. The depletion of an RPA subunit, Rfa1, in a recombination-defective dmc1 mutant, fully alleviates the pachytene arrest with the persistent unrepaired DSBs. RPA depletion decreases the activity of a meiosis-specific CHK2 homolog, Mek1 kinase, which in turn activates the Ndt80 transcriptional regulator for pachytene exit. These support the idea that RPA is a sensor of ssDNAs for the activation of meiotic DDR. Rfa1 depletion also accelerates the prophase I delay in the zip1 mutant defective in both chromosome synapsis and the recombination, consistent with the notion that the accumulation of ssDNAs rather than defective synapsis triggers prophase I delay in the zip1 mutant.


Sujet(s)
Cassures double-brin de l'ADN , Méiose , Protéine A de réplication , Protéines de Saccharomyces cerevisiae , Saccharomyces cerevisiae , Facteurs de transcription , Protéine A de réplication/métabolisme , Protéine A de réplication/génétique , Saccharomyces cerevisiae/métabolisme , Saccharomyces cerevisiae/génétique , Protéines de Saccharomyces cerevisiae/métabolisme , Protéines de Saccharomyces cerevisiae/génétique , Protéines du cycle cellulaire/métabolisme , Protéines du cycle cellulaire/génétique , Protéines de liaison à l'ADN/métabolisme , Protéines de liaison à l'ADN/génétique , Recombinaison génétique , Recombinaison homologue , MAP Kinase Kinase 1/métabolisme , MAP Kinase Kinase 1/génétique , ADN simple brin/métabolisme , ADN simple brin/génétique , Protéines nucléaires/métabolisme , Protéines nucléaires/génétique
15.
Sci Rep ; 14(1): 8369, 2024 Apr 10.
Article de Anglais | MEDLINE | ID: mdl-38600289

RÉSUMÉ

LoRaWAN has become the technology of choice for increasing Internet of Things applications owing to its long range and low power consumption characteristics. However, in the uplink confirmed messaging cases, the entire retransmission could take several seconds, so it cannot be used in scenarios that require rapid confirmed messaging, such as emergency alerting and real-time controlling applications. Nevertheless, there has been limited work targeting this issue. This study presents a novel LoRaWAN gateway using edge computing to expedite the confirmed messaging process by generating the acknowledgment (ACK) locally, so that the confirmed messaging time can be significantly reduced. Additionally, the resource utilization of the network server can also be decreased due to the use of edge computing. We verified the effectiveness of our solution through extensive simulations and experiments. The confirmed messaging time between the end nodes and the gateway averaged 43 ms for a maximum of 2 retransmissions. With the adoption of edge computing on the gateway, the network server's central processing unit (CPU), memory, and bandwidth peak utilization decrease from 53.51 to 39.46, 73.88 to 72.11%, and 4422.68 kbps to 3271.27 kbps, respectively. In addition, the network server's system load decreases from 2.15 to 1.69, while the gateway cost is reduced by almost $ 38 compared to the benchmark products.

16.
Fish Shellfish Immunol ; 149: 109579, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38648996

RÉSUMÉ

As a potent antioxidant, the flavonoid compound quercetin (QUE) has been widely used in the farming of aquatic animals. However, there are fewer reports of the beneficial effects, especially in improving immunity of Penaeus vannamei by QUE. The aim of this study was to investigate the effects of dietary QUE on growth, apoptosis, antioxidant and immunity of P. vannamei. It also explored the potential mechanisms of QUE in improving the growth and immunity of P. vannamei. P. vannamei were fed diets with QUE for 60 days. The results revealed that QUE (0.5 or 1.0 g/kg) ameliorated the growth, and the expressions of genes related to apoptosis, antioxidant, and immunity. The differentially expressed genes (DEGs) and differential metabolites (DMs) obtained through transcriptomics and metabolomics, respectively, enriched in pathways related to nutritional metabolism such as lipid metabolism, amino acid metabolism, and carbohydrate metabolism. After QUE addition, especially at 0.5 g/kg, DEGs were enriched into the functions of response to stimulus and antioxidant activity, and the pathways of HIF-1 signaling pathway, C-type lectin receptor signaling pathway, Toll-like receptor signaling pathway, and FoxO signaling pathway. In conclusion, dietary QUE can ameliorate growth, apoptosis, antioxidant and immunity of P. vannamei, the appropriate addition amount was 0.5 g/kg rather than 1.0 g/kg. Regulations of QUE on nutrient metabolism and immune-related pathways, and bioactive metabolites, were important factors for improving the aforementioned abilities in P. vannamei.


Sujet(s)
Aliment pour animaux , Régime alimentaire , Compléments alimentaires , Penaeidae , Quercétine , Transcriptome , Animaux , Penaeidae/immunologie , Penaeidae/croissance et développement , Penaeidae/génétique , Penaeidae/effets des médicaments et des substances chimiques , Quercétine/administration et posologie , Quercétine/pharmacologie , Régime alimentaire/médecine vétérinaire , Transcriptome/effets des médicaments et des substances chimiques , Aliment pour animaux/analyse , Compléments alimentaires/analyse , Métabolomique , Immunité innée/effets des médicaments et des substances chimiques , Analyse de profil d'expression de gènes/médecine vétérinaire , Antioxydants/métabolisme
17.
Adv Mater ; 36(25): e2400099, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38481340

RÉSUMÉ

Multifunctional flexible electronics present tremendous opportunities in the rapidly evolving digital age. One potential avenue to realize this goal is the integration of polyoxometalates (POMs) and ionic liquid-based gels (ILGs), but the challenge of macrophase separation due to poor compatibility, especially caused by repulsion between like-charged units, poses a significant hurdle. Herein, the possibilities of producing diverse and homogenous POMs-containing ionohydrogels by nanoconfining POMs and ionic liquids (ILs) within an elastomer-like polyzwitterionic hydrogel using a simple one-step random copolymerization method, are expanded vastly. The incorporation of polyzwitterions provides a nanoconfined microenvironment and effectively modulates excessive electrostatic interactions in POMs/ILs/H2O blending system, facilitating a phase transition from macrophase separation to a submillimeter scale worm-like microphase-separation system. Moreover, combining POMs-reinforced ionohydrogels with a developed integrated self-powered sensing system utilizing strain sensors and Zn-ion hybrid supercapacitors has enabled efficient energy storage and detection of external strain changes with high precision. This work not only provides guidelines for manipulating morphology within phase-separation gelation systems, but also paves the way for developing versatile POMs-based ionohydrogels for state-of-the-art smart flexible electronics.

18.
Cell Rep ; 43(3): 113877, 2024 Mar 26.
Article de Anglais | MEDLINE | ID: mdl-38421869

RÉSUMÉ

Combination therapy (lenvatinib/programmed death-1 inhibitor) is effective for treating unresectable hepatocellular carcinoma (uHCC). We reveal that responders have better overall and progression-free survival, as well as high tumor mutation burden and special somatic variants. We analyze the proteome and metabolome of 82 plasma samples from patients with hepatocellular carcinoma (HCC; n = 51) and normal controls (n = 15), revealing that individual differences outweigh treatment differences. Responders exhibit enhanced activity in the alternative/lectin complement pathway and higher levels of lysophosphatidylcholines (LysoPCs), predicting a favorable prognosis. Non-responders are enriched for immunoglobulins, predicting worse outcomes. Compared to normal controls, HCC plasma proteins show acute inflammatory response and platelet activation, while LysoPCs decrease. Combination therapy increases LysoPCs/phosphocholines in responders. Logistic regression/random forest models using metabolomic features achieve good performance in the prediction of responders. Proteomic analysis of cancer tissues unveils molecular features that are associated with side effects in responders receiving combination therapy. In conclusion, our analysis identifies plasma features associated with uHCC responders to combination therapy.


Sujet(s)
Carcinome hépatocellulaire , Tumeurs du foie , Phénylurées , Quinoléines , Humains , Carcinome hépatocellulaire/traitement médicamenteux , Protéomique , Tumeurs du foie/traitement médicamenteux , Association thérapeutique
19.
PeerJ Comput Sci ; 10: e1738, 2024.
Article de Anglais | MEDLINE | ID: mdl-38196958

RÉSUMÉ

This study introduces a novel approach, Local Spatial Projection Convolution (LSPConv), for point cloud classification and semantic segmentation. Unlike conventional methods utilizing relative coordinates for local geometric information, our motivation stems from the inadequacy of existing techniques for representing the intricate spatial organization of unconsolidated and irregular 3D point clouds. To address this limitation, we propose a Local Spatial Projection Module utilizing a vector projection strategy, designed to capture comprehensive local spatial information more effectively. Moreover, recent studies emphasize the importance of anisotropic kernels for point cloud feature extraction, considering the distinct contributions of individual neighboring points. To cater to this requirement, we introduce the Feature Weight Assignment (FWA) Module to assign weights to neighboring points, enhancing the anisotropy crucial for accurate feature extraction. Additionally, we introduce an Anisotropic Relative Feature Encoding Module that adaptively encodes points based on their relative features, further amplifying the anisotropic characteristics. Our approaches achieve remarkable results for point cloud classification and segmentation in several benchmark datasets based on extensive qualitative and quantitative evaluation.

20.
Article de Chinois | WPRIM (Pacifique Occidental) | ID: wpr-1023388

RÉSUMÉ

Objective:To investigate the current status and problems of the development of dental technology specialty in higher vocational colleges in China, and to provide a reference for the establishment of national standards for vocational education on dental technology and the development of high-quality higher vocational education.Methods:We selected 54 higher vocational colleges in eastern, central, and western China offering dental technology programs by stratified random sampling to survey the specialty development situation using a questionnaire. Data were analyzed using the independent samples t test, one-way analysis of variance, or chi-square test with the use of SPSS 18.0. Results:Among the surveyed colleges, the average annual enrollment scale in recent three years was 6 415 students, with the largest enrollment in western regions, accounting for 47.39%. In terms of teaching faculty, there were differences in educational attainment, professional title structure, vocational qualification, and professional background between different regions ( P<0.05). Regarding training conditions, only 26.42% and 3.77% of colleges were equipped with virtual simulation training rooms and dental materials training rooms, respectively; and 18.52% and 22.22% of colleges were equipped with chairside repair systems and virtual simulation software, respectively. Conclusions:Regional imbalances exist in the development of dental technology specialty in higher vocational colleges in China. The overall level of teaching staff, practical training conditions, and curriculum construction need to be improved.

SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE